FIELD: medicine, obstetrics.
SUBSTANCE: starting from 22nd wk of pregnancy it is necessary to detect the concentration of neurospecific enolase and glyofibrous acid protein in blood serum. The development of gestosis in pregnant women should be predicted by the value of neurospecific enolase being above 12.4 ng/ml and glyofibrous acid protein being above 4 ng/ml. Moreover, severe gestosis should be predicted at the value of neurospecific enolase being 19 ng/ml and higher and glyofibrous acid protein being 10 ng/ml and higher. Application of the method enables to increase the accuracy of prediction.
EFFECT: higher efficiency and accuracy of prediction.
1 cl, 4 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD FOR PREDICTING GESTOSIS | 2005 |
|
RU2287823C1 |
| METHOD FOR PREDICTION OF THE RISK OF DEVELOPING SEVERE COMPLICATIONS OF PREECLAMPSIA | 2020 |
|
RU2741730C1 |
| METHOD FOR PREDICTION OF PREECLAMPSIA IN SECOND TRIMESTER OF PREGNANCY | 2014 |
|
RU2552931C1 |
| METHOD OF EARLY PREDICTION OF PREECLAMPSIA PROGRESSION | 2016 |
|
RU2648872C1 |
| METHOD OF PREDICTING PREECLAMPSIA THERAPY EFFICIENCY | 2011 |
|
RU2475753C1 |
| METHOD FOR PREDICTION OF ONSET OF GESTOSIS IN PREGNANT WOMEN | 2011 |
|
RU2478960C2 |
| METHOD FOR PREDICTING LATE GESTOSIS | 1995 |
|
RU2107916C1 |
| METHOD FOR PREDICTING THE EFFECTIVENESS OF THE TREATMENT OF MODERATE PREECLAMPSIA | 2019 |
|
RU2705374C1 |
| METHOD FOR FORECASTING DEVELOPMENT OF PRE-ECLAMPSIA IN LATE PREGNANCY | 2018 |
|
RU2691114C1 |
| METHOD OF PREDICTING LATE TOXICOSIS IN PREGNANT COWS | 2023 |
|
RU2802503C1 |
